Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

Author:

Rossello Xavier12,Dorresteijn Jannick AN3,Janssen Arne4,Lambrinou Ekaterini45,Scherrenberg Martijn67,Bonnefoy-Cudraz Eric8,Cobain Mark9,Piepoli Massimo F10,Visseren Frank LJ2,Dendale Paul67

Affiliation:

1. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain

2. Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Spain

3. Department of Vascular Medicine, University Medical Center Utrecht, The Netherlands

4. Clinical Research Department Cardiology, Heartcentre Hasselt, Jessa Hospital, Hasselt, Belgium

5. Department of Nursing, Cyprus University of Technology, Cyprus

6. Jessa Hospital, Heartcentre Hasselt, Belgium

7. Faculty of Medicine and Life Sciences, Hasselt University, Belgium

8. Department of Cardiology, Hôpital cardiologique de Lyon, France

9. Department of Cardiovascular Medicine, Imperial College, UK

10. Heart Failure Unit, Cardiology, G da Saliceto Hospital, Italy, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Abstract

Abstract Risk assessment and risk prediction have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of – usually interactive and online available – tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the U-prevent.com website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology.

Funder

the European Association of Preventive Cardiology

the Acute Cardiovascular Care Association

the Association of Cardiovascular Nursing and Allied Professions

the ESC Prevention of Cardiovascular Disease Programme

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Reference57 articles.

1. 2016 European Guidelines on cardiovascular disease prevention in clinical practice;Piepoli;Eur Heart J,2016

2. World Health Organization. The top 10 causes of death: Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva: World Health Organization; 2018. www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed 20 October 2018).

3. Long-term use of cardiovascular drugs;Rossello;J Am Coll Cardiol,2015

4. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials;Rossello;Clin Res Cardiol,2019

5. Cardiovascular risk estimation in older persons: SCORE O.P;Cooney;Eur J Prev Cardiol,2016

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3